Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CDK9 antibody (N-Term)

The Rabbit Polyclonal anti-CDK9 antibody has been validated for WB. It is suitable to detect CDK9 in samples from Human.
Catalog No. ABIN6971511

Quick Overview for CDK9 antibody (N-Term) (ABIN6971511)

Target

See all CDK9 Antibodies
CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Reactivity

  • 99
  • 47
  • 21
  • 7
  • 5
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Human

Host

  • 95
  • 4
  • 2
Rabbit

Clonality

  • 85
  • 16
Polyclonal

Conjugate

  • 46
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This CDK9 antibody is un-conjugated

Application

  • 76
  • 29
  • 27
  • 26
  • 17
  • 15
  • 13
  • 12
  • 10
  • 8
  • 7
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Binding Specificity

    • 25
    • 15
    • 10
    • 6
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Characteristics

    CDK9 (cyclin-dependent kinase 9) is a protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3, integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. CDK9 antibody (pAb) was raised in a Rabbit host. It has been validated for use in Western blot, it has been shown to react with Human samples.

    Purification

    Affinity Purified

    Immunogen

    This antibody was raised against a peptide within the N-terminal region of human CDK9.

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Buffer

    Purified IgG in 70 mM Tris ( pH 8), 105 mM NaCl, 31 mM glycine, 0.07 mM EDTA, 30 % glycerol and 0.035 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
  • Target

    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

    Alternative Name

    CDK9

    Molecular Weight

    44 kDa

    NCBI Accession

    NP_001252

    Pathways

    Cell Division Cycle
You are here:
Chat with us!